These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8591933)

  • 21. [Update on hepatitis C: potential transmission by invasive medical examinations; new therapeutic modalities (1)].
    Delwaide J
    Rev Med Liege; 1998 Aug; 53(8):467-9. PubMed ID: 9810206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.
    Brok J; Gluud LL; Gluud C
    Arch Intern Med; 2005 Oct; 165(19):2206-12. PubMed ID: 16246984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S91-3. PubMed ID: 19375041
    [No Abstract]   [Full Text] [Related]  

  • 24. Peginterferon alfa-2b and ribavirin in thalassaemia/chronic hepatitis C virus-co-infected non-responder to standard interferon-based.
    Hamidah A; Thambidorai CR; Jamal R
    Med J Malaysia; 2005 Oct; 60(4):517-9. PubMed ID: 16570722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.
    Xirouchakis E; Triantos C; Manousou P; Sigalas A; Calvaruso V; Corbani A; Leandro G; Patch D; Burroughs A
    J Viral Hepat; 2008 Oct; 15(10):699-709. PubMed ID: 18673428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prompt arrival of antivirals against hepatitis C for HIV patients.
    Barreiro P; Vispo E
    AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779
    [No Abstract]   [Full Text] [Related]  

  • 27. [Editorial commentary: Hepatitis C].
    Pár A
    Orv Hetil; 2015 May; 156(21):835. PubMed ID: 26038989
    [No Abstract]   [Full Text] [Related]  

  • 28. Advisory panel: expand hepatitis therapy to HIV/AIDS patients.
    AIDS Policy Law; 2002 Jul; 17(12):2. PubMed ID: 12134793
    [No Abstract]   [Full Text] [Related]  

  • 29. [Infectious diseases in 1998].
    Bricaire F
    Rev Med Interne; 1999 Apr; 20(4):365-8. PubMed ID: 10327482
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of chronic hepatitis C: another therapeutic option.
    Trepo C; Bailly F; Bizollon T
    Nephrol Dial Transplant; 1996; 11 Suppl 4():62-4. PubMed ID: 8918759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C.
    Wkly Epidemiol Rec; 2011 Oct; 86(41):445-7. PubMed ID: 21984985
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chronic hepatitis C. A new chance with Consensus Interferon for patients with handicaps].
    MMW Fortschr Med; 2002 Nov; 144(45):56-7. PubMed ID: 12534066
    [No Abstract]   [Full Text] [Related]  

  • 34. Future therapies for hepatitis C.
    Pawlotsky JM; Gish RG
    Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The smoldering epidemic. The number of new cases of hepatitis C is down, but millions are chronically infected and may not know it.
    Harv Health Lett; 2010 Sep; 35(11):1-3. PubMed ID: 20939121
    [No Abstract]   [Full Text] [Related]  

  • 36. Ribavirin plus interferon versus interferon for chronic hepatitis C.
    Brok J; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2005 Jul; (3):CD005445. PubMed ID: 16034976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New drugs for hepatitis C].
    Färkkilä M
    Duodecim; 2014; 130(18):1813-22. PubMed ID: 25558623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment strategies of acute and chronic hepatitis C].
    Gładysz A; Inglot M
    Przegl Epidemiol; 2002; 56 Suppl 5():10-5. PubMed ID: 15553066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing hepatitis C infection in HIV-positive patients.
    Craven DE; Nunes DP
    AIDS Clin Care; 2000 Sep; 12(9):71-5, 78. PubMed ID: 12170952
    [No Abstract]   [Full Text] [Related]  

  • 40. Digestive Disease Week 2000 conference report: New treatments for chronic hepatitis C.
    Brown PJ; Neuman MG
    Can J Clin Pharmacol; 2001; 8(2):67-71. PubMed ID: 11493933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.